Chemical inhibitors of MPPED2 encompass a variety of substances that interact with the enzyme in different ways to inhibit its function. Staurosporine, a broad-spectrum protein kinase inhibitor, can indirectly lead to the inhibition of MPPED2 by suppressing the kinase signaling pathways that are involved in the regulation of MPPED2 activity. This results in a reduced phosphorylation of proteins that are necessary for MPPED2's optimal function. Similarly, okadaic acid, which specifically targets protein phosphatases like PP1 and PP2A, can disrupt the delicate balance of phosphorylation within the cell, potentially altering the regulation of MPPED2 and hence its activity. Sodium orthovanadate, on the other hand, inhibits protein tyrosine phosphatases, and its action can lead to changes in tyrosine phosphorylation status that are crucial for the activity of MPPED2.
Furthermore, the enzymatic function of MPPED2 can be directly influenced by the presence of metal ions, and zinc chloride demonstrates this by potentially competing with the metal cofactors necessary for MPPED2 activity, thereby inhibiting it. Bafilomycin A1, a V-ATPase inhibitor, can disrupt intracellular pH and proton gradients, which are possible modulators of MPPED2 function. Concanavalin A, known for its ability to bind to glycoproteins, can inhibit MPPED2 by potentially altering its glycosylation pattern, affecting its folding and stability. Cyclosporin A, which inhibits calcineurin, can impede the calcineurin pathway that may regulate MPPED2, leading to its inhibition. In contrast, tetrabromobisphenol A might interfere with bromination patterns essential for the activity of MPPED2, resulting in inhibition. Genistein's role in blocking tyrosine kinase signaling pathways can lead to the inhibition of MPPED2 if those pathways are involved in its activation. Phosphoramidon, a metalloprotease inhibitor, can affect the activity of MPPED2 if there is a functional relationship between MPPED2 and metalloproteases. Lastly, α-Ketoisocaproate and 2-Mercaptobenzothiazole can inhibit MPPED2 by disrupting the associated metabolism of branched-chain amino acids and by chelating metal ions necessary for MPPED2's metallophosphoesterase activity, respectively.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. MPPED2, as a metallophosphoesterase, may be indirectly inhibited by staurosporine through the kinase signaling pathways that regulate MPPED2 activity. Staurosporine's broad-spectrum kinase inhibition can lead to a decrease in phosphorylation-dependent activation processes, thereby reducing MPPED2's functional activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a specific inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A). MPPED2's function could be inhibited by an imbalance in phosphorylation states due to the prevention of dephosphorylation by okadaic acid, which can indirectly lead to altered regulation of MPPED2 activity. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is an inhibitor of protein tyrosine phosphatases. By inhibiting these phosphatases, MPPED2 could be functionally inhibited if its activity is regulated by tyrosine phosphorylation status, which would be altered by the action of sodium orthovanadate. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc chloride can act as an inhibitor of many metalloenzymes. If MPPED2 requires metal cofactors for its activity, the presence of excess zinc could competitively inhibit the binding of the necessary metals, thus inhibiting MPPED2's enzymatic function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of the V-ATPase proton pump. If MPPED2's functionality is linked to the proton gradient or intracellular pH maintained by V-ATPase, then disruption of this gradient by bafilomycin A1 could inhibit MPPED2 activity. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Concanavalin A is a lectin that can bind to glycoproteins and inhibit their function. If MPPED2 is glycosylated and this modification is essential for its activity, concanavalin A binding could inhibit its function by steric hindrance or by altering its folding and stability. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressive agent that can inhibit calcineurin. If MPPED2 is regulated by the calcineurin pathway, inhibition of calcineurin by cyclosporin A would result in inhibition of MPPED2 activity. | ||||||
3,3′,5,5′-Tetrabromobisphenol A | 79-94-7 | sc-238640 sc-238640A | 100 g 500 g | $82.00 $194.00 | 2 | |
Tetrabromobisphenol A is a brominated flame retardant that can interfere with several enzymes. If MPPED2 requires specific bromination patterns for activity, tetrabromobisphenol A could inhibit MPPED2 by disrupting these patterns. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. If MPPED2 activity is regulated by tyrosine kinase signaling, genistein could inhibit its activity by blocking the signaling pathways that activate MPPED2. | ||||||
Phosphoramidon | 119942-99-3 | sc-201283 sc-201283A | 5 mg 25 mg | $199.00 $632.00 | 8 | |
Phosphoramidon is a metalloprotease inhibitor. If MPPED2 has a functional interplay with metalloproteases, inhibition of these proteases by phosphoramidon could result in the inhibition of MPPED2's activity. | ||||||